Literature DB >> 21708257

Neuropeptide S inhibits stress-stimulated faecal output in the rat.

Carla Petrella1, Simona Agostini, Remo Guerrini, Girolamo Calò, Alessia Giaquinto, Chiara De Nuccio, Giovanna Improta, Maria Broccardo.   

Abstract

Neuropeptide S (NPS) is a recently identified bioactive peptide that activates an orphan G-protein coupled receptor, called the NPS receptor (NPSR). In rats, NPS and NPSR constitute a novel neuropeptide system expressed both in the central nervous system and in peripheral tissues, controlling visceromotor, neuroendocrine, nociceptive and behavioural responses. To improve the knowledge of the role of the NPS-NPSR system in the gastrointestinal (GI) tract, we investigated: 1- the supraspinal effect of NPS on motor functions of the upper (gastric emptying and gastrointestinal transit) and lower (distal colonic transit and faecal output) GI tract under basal conditions, 2- during pathological states (restraint stress and corticotropin releasing factor (CRF)-induced defecation) in the rat, and 3- the receptor type involved in treatment with NPS using NPS, tachykinin NK(3) and opioid receptor antagonists (([D-Cys(tBu)⁵]NPS), SR142801 and naloxone, respectively). Intracerebroventricular injection of NPS failed to modify basal gastric emptying, gastrointestinal transit and distal colon propulsion, but significantly and dose-dependently reduced faecal pellet excretion and weight stimulated by restraint stress and CRF. The inhibitory effect of NPS on stress-induced defecation was unmodified by pre-treatment with either the tachykinin or opioid receptor antagonists, but was counteracted by a NPSR antagonist. The present study demonstrates, for the first time, that the supraspinal NPS system, which does not participate in the physiological control of GI motility, plays an inhibitory role on defecation stimulated by restraint stress and CRF. The combination of the ability of NPS to inhibit faecal output together with its known anxiolytic effect may be promising, especially in pathological conditions such as irritable bowel syndrome, where stress and the hyperactivity of the CRF system contribute to the co-morbidity of anxiety with colonic motor symptoms such as diarrhoea.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21708257     DOI: 10.1016/j.phrs.2011.06.007

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  5 in total

1.  Increased GABAergic Efficacy of Central Amygdala Projections to Neuropeptide S Neurons in the Brainstem During Fear Memory Retrieval.

Authors:  Kay Jüngling; Maren D Lange; Hanna J Szkudlarek; Jörg Lesting; Frank S Erdmann; Michael Doengi; Sebastian Kügler; Hans-Christian Pape
Journal:  Neuropsychopharmacology       Date:  2015-05-04       Impact factor: 7.853

2.  Central neuropeptide-S administration alleviates stress-induced impairment of gastric motor functions through orexin-A.

Authors:  Mehmet Bülbül; Osman Sinen; Onur Bayramoğlu
Journal:  Turk J Gastroenterol       Date:  2020-01       Impact factor: 1.852

Review 3.  Novel transmitters in brain stem vagal neurocircuitry: new players on the pitch.

Authors:  Mehmet Bülbül; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-29       Impact factor: 4.052

4.  Neuropeptide S reduces duodenal bicarbonate secretion and ethanol-induced increases in duodenal motility in rats.

Authors:  Wan Salman Wan Saudi; Markus Sjöblom
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

Review 5.  The Neural Network of Neuropeptide S (NPS): Implications in Food Intake and Gastrointestinal Functions.

Authors:  Luca Botticelli; Emanuela Micioni Di Bonaventura; Massimo Ubaldi; Roberto Ciccocioppo; Carlo Cifani; Maria Vittoria Micioni Di Bonaventura
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.